Related Experiment Video
Updated: May 12, 2026

12:05
Co-staining Blood Vessels and Nerve Fibers in Adipose Tissue
Published on: February 13, 2019
Adipose tissue angiogenesis in obesity
Amal Y Lemoine1, Séverine Ledoux, Etienne Larger
1Prof. Etienne Larger, Service de Diabétologie, Hôtel Dieu, Parvis de Notre Dame, F-75004 Paris, France,
Thrombosis and Haemostasis
|April 19, 2013
Summary
Adipose tissue angiogenesis, the growth of blood vessels, is crucial for weight changes. Understanding its regulation offers potential obesity and metabolic disease treatments.
Area of Science:
- * Physiology and molecular biology of adipose tissue.
- * Vascular biology and angiogenesis.
- * Metabolic disease research.
Background:
- * Adipose tissue is highly plastic, undergoing constant remodeling during weight fluctuations.
- * Vascularization, through angiogenesis, must adapt to adipose tissue expansion and regression.
- * Adipose tissue exhibits significant angiogenic capacity, involving interactions between adipocytes and blood vessels.
Purpose of the Study:
- * To review the regulation of adipose tissue angiogenesis.
- * To discuss growth factors involved in vascular changes within adipose tissue.
- * To explore the link between adipose tissue angiogenesis, inflammation, insulin resistance, and metabolic diseases.
Main Methods:
- * Comprehensive review of existing scientific literature on adipose tissue angiogenesis.
- * Analysis of studies investigating angiogenic and anti-angiogenic factors.
- * Examination of the relationship between vascular changes and metabolic health.
Main Results:
- * Adipose tissue angiogenesis is tightly regulated by interactions between adipocytes and blood vessels.
- * Specific growth factors drive both blood vessel formation and regression in adipose tissue.
- * Altered angiogenesis in adipose tissue may contribute to inflammation and insulin resistance.
Conclusions:
- * Understanding adipose tissue angiogenesis is key to developing obesity treatments.
- * Modulating angiogenic factors presents therapeutic potential for metabolic diseases.
- * The role of adipose tissue angiogenesis in metabolic dysfunction requires further investigation.
Related Concept Videos
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Hypodermis
The hypodermis (the subcutaneous layer or superficial fascia) is present directly below the dermis. It connects the skin to the underlying fascia (fibrous tissue) of the bones and muscles. It is not strictly a part of the skin, although the border between the hypodermis and dermis can be difficult to distinguish. The hypodermis consists of well-vascularized, loose, areolar connective tissue and adipose tissue, which functions as a mode of fat storage and provides insulation and cushioning for...
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

